<VariationArchive VariationID="200672" VariationName="NM_000238.4(KCNH2):c.2775dup (p.Pro926fs)" VariationType="Duplication" Accession="VCV000200672" Version="21" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="7" DateLastUpdated="2024-07-29" DateCreated="2016-10-13" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="197175" VariationID="200672">
      <GeneList>
        <Gene Symbol="KCNH2" FullName="potassium voltage-gated channel subfamily H member 2" GeneID="3757" HGNC_ID="HGNC:6251" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q36.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="150944961" stop="150978321" display_start="150944961" display_stop="150978321" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="150642043" stop="150675401" display_start="150642043" display_stop="150675401" Strand="-" />
          </Location>
          <OMIM>152427</OMIM>
          <Haploinsufficiency last_evaluated="2020-02-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNH2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-02-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNH2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000238.4(KCNH2):c.2775dup (p.Pro926fs)</Name>
      <CanonicalSPDI>NC_000007.14:150947795:CCCCCCC:CCCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q36.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="150947795" stop="150947796" display_start="150947795" display_stop="150947796" variantLength="1" positionVCF="150947795" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="150644883" stop="150644884" display_start="150644883" display_stop="150644884" variantLength="1" positionVCF="150644883" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>P926fs</ProteinChange>
      <ProteinChange>P586fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.150644890dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.150644890dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.150947802dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.150947802dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008916.1" sequenceAccession="NG_008916" sequenceVersion="1" change="g.35131dup">
            <Expression>NG_008916.1:g.35131dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000238.4" sequenceAccession="NM_000238" sequenceVersion="4" change="c.2775dup" MANESelect="true">
            <Expression>NM_000238.4:c.2775dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000229.1" sequenceAccession="NP_000229" sequenceVersion="1" change="p.Pro926fs">
            <Expression>NP_000229.1:p.Pro926fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172057.3" sequenceAccession="NM_172057" sequenceVersion="3" change="c.1755dup">
            <Expression>NM_172057.3:c.1755dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742054.1" sequenceAccession="NP_742054" sequenceVersion="1" change="p.Pro586fs">
            <Expression>NP_742054.1:p.Pro586fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_288" sequenceAccession="LRG_288">
            <Expression>LRG_288:g.35131dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_288t1" sequenceAccession="LRG_288t1">
            <Expression>LRG_288t1:c.2775dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_288p1" sequenceAccession="LRG_288p1" change="p.Pro926fs">
            <Expression>LRG_288p1:p.Pro926fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000238.3" sequenceAccession="NM_000238" sequenceVersion="3" change="c.2775dupG">
            <Expression>NM_000238.3:c.2775dupG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000238.2" sequenceAccession="NM_000238" sequenceVersion="2" change="c.2775dup">
            <Expression>NM_000238.2:c.2775dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA305328" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="152427.0020" DB="OMIM" />
        <XRef Type="rs" ID="794728455" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000238.4(KCNH2):c.2775dup (p.Pro926fs) AND Long QT syndrome 2" Accession="RCV000015520" Version="31">
        <ClassifiedConditionList TraitSetID="3981">
          <ClassifiedCondition DB="MedGen" ID="C3150943">Long QT syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000238.4(KCNH2):c.2775dup (p.Pro926fs) AND Long QT syndrome 1/2, digenic" Accession="RCV000015521" Version="34">
        <ClassifiedConditionList TraitSetID="10599">
          <ClassifiedCondition DB="MedGen" ID="C3277700">Long QT syndrome 1/2, digenic</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000238.4(KCNH2):c.2775dup (p.Pro926fs) AND not provided" Accession="RCV000181993" Version="13">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-05" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000238.4(KCNH2):c.2775dup (p.Pro926fs) AND Long QT syndrome" Accession="RCV000204205" Version="21">
        <ClassifiedConditionList TraitSetID="8775">
          <ClassifiedCondition DB="MedGen" ID="C0023976">Long QT syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-04" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000238.4(KCNH2):c.2775dup (p.Pro926fs) AND Cardiovascular phenotype" Accession="RCV000249424" Version="13">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000238.4(KCNH2):c.2775dup (p.Pro926fs) AND Cardiac arrhythmia" Accession="RCV001842847" Version="11">
        <ClassifiedConditionList TraitSetID="32411">
          <ClassifiedCondition DB="MedGen" ID="C0003811">Cardiac arrhythmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-04" NumberOfSubmissions="8" NumberOfSubmitters="7" DateCreated="2016-10-13" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10973849</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16922724</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19862833</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20181576</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21419236</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26669661</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27000522</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30369311</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32383558</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3981" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="6428" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 2</ElementValue>
                <XRef ID="Long+QT+syndrome+2/4300" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013367" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT2</ElementValue>
                <XRef Type="MIM" ID="613688" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3285" />
                <XRef ID="3285" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C3150943" DB="MedGen" />
              <XRef ID="MONDO:0013367" DB="MONDO" />
              <XRef Type="MIM" ID="613688" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8775" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16506" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome</ElementValue>
                <XRef ID="Long+QT+Syndrome/4296" DB="Genetic Alliance" />
                <XRef ID="MONDO:0002442" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS192500" DB="OMIM" />
                <XRef ID="9651007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQTS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LQT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000522197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592276" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528500" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558315" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520446" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515873" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523361" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528497" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520456" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000555634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591169" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519089" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522200" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000559512" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520458" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511116" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552174" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Various modes of inheritance</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C0023976" DB="MedGen" />
              <XRef ID="D008133" DB="MeSH" />
              <XRef ID="MONDO:0002442" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32411" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1082" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cardiac rhythm disease</ElementValue>
                <XRef ID="MONDO:0007263" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cardiac arrhythmia</ElementValue>
                <XRef ID="698247007" DB="SNOMED CT" />
              </Name>
              <XRef ID="C0003811" DB="MedGen" />
              <XRef ID="EFO_0004269" DB="EFO" />
              <XRef ID="MONDO:0007263" DB="MONDO" />
              <XRef Type="primary" ID="HP:0011675" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001656" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001661" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001665" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001666" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001687" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001721" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004351" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005158" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10599" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8576" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 1/2, digenic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Long QT syndrome 1/2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT1/2, DIGENIC</ElementValue>
                <XRef ID="192500" DB="OMIM" />
              </Symbol>
              <XRef ID="C3277700" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="35785" SubmissionDate="2017-04-23" DateLastUpdated="2017-04-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="152427.0020_LONG QT SYNDROME 2" title="KCNH2, 1-BP INS, 2775G_LONG QT SYNDROME 2" />
        <ClinVarAccession Accession="SCV000035785" DateUpdated="2017-04-26" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with long QT syndrome (LQT2; 613688), Splawski et al. (2000) identified heterozygosity for a 1-bp insertion (2775insG) in exon 12 of the KCNH2 gene, causing a frameshift at pro926 that results in a termination signal 13 codons downstream.</Attribute>
              <Citation>
                <ID Source="PubMed">10973849</ID>
              </Citation>
              <XRef DB="OMIM" ID="613688" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a female infant with a family history of sudden death, who had severe, continuous bradycardia in utero that was confirmed after birth and a QTc of 485 ms, Millat et al. (2006) identified biallelic digenic mutations: 2775insG in the KCNH2 gene and a deletion in the KCNQ1 gene (562delT; 607542.0038).</Attribute>
              <Citation>
                <ID Source="PubMed">16922724</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2" />
          </GeneList>
          <Name>KCNH2, 1-BP INS, 2775G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 2775G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="152427.0020" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LONG QT SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="35786" SubmissionDate="2017-04-23" DateLastUpdated="2016-10-13" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="152427.0020_LONG QT SYNDROME 1/2, DIGENIC" title="KCNH2, 1-BP INS, 2775G_LONG QT SYNDROME 1/2, DIGENIC" />
        <ClinVarAccession Accession="SCV000035786" DateUpdated="2016-10-13" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with long QT syndrome (LQT2; 613688), Splawski et al. (2000) identified heterozygosity for a 1-bp insertion (2775insG) in exon 12 of the KCNH2 gene, causing a frameshift at pro926 that results in a termination signal 13 codons downstream.</Attribute>
              <Citation>
                <ID Source="PubMed">10973849</ID>
              </Citation>
              <XRef DB="OMIM" ID="613688" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a female infant with a family history of sudden death, who had severe, continuous bradycardia in utero that was confirmed after birth and a QTc of 485 ms, Millat et al. (2006) identified biallelic digenic mutations: 2775insG in the KCNH2 gene and a deletion in the KCNQ1 gene (562delT; 607542.0038).</Attribute>
              <Citation>
                <ID Source="PubMed">16922724</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2" />
          </GeneList>
          <Name>KCNH2, 1-BP INS, 2775G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 2775G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="152427.0020" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">LONG QT SYNDROME 1/2, DIGENIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="485295" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2016-01-31">
        <ClinVarSubmissionID localKey="458886|MedGen:C0023976" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000260323" DateUpdated="2024-02-14" DateCreated="2016-01-31" Type="SCV" Version="11" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10973849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19862833</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10973849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20181576</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21419236</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro926Alafs*14) in the KCNH2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNH2 are known to be pathogenic (PMID: 10973849, 19862833). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with long QT syndrome (PMID: 10973849, 20181576, 21419236). ClinVar contains an entry for this variant (Variation ID: 200672). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.150644883_150644884insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023976" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9024331" SubmissionDate="2024-04-16" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="1465602|MONDO:0002442" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004835932" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="All of Us Research Program, National Institutes of Health" OrgID="509529" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10973849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20181576</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21419236</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26669661</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27000522</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30369311</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32383558</ID>
          </Citation>
          <Comment>This variant causes a duplication of 1 nucleotide in exon 12 of the KCNH2 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. Functional studies have shown that this variant causes decreased expression of KCNH2 resulting in a reduction in channel current density in HEK293 cells (PMID: 20181576, 21419236). This variant has been reported in at least eight unrelated individuals affected with long QT syndrome (PMID: 10973849, 21419236, 20181576, 26669661, 30369311, 32383558). It has been shown that this variant segregates with disease in multiple individuals from two of these families (PMID: 20181576, 21419236). This variant has also been reported in an individual affected with sudden cardiac death (PMID: 27000522). This variant has been identified in 1/127658 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of KCNH2 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>108544</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.150644884dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0002442" />
          </Trait>
        </TraitSet>
        <Comment>This study involves interpretation of variants in research participants for the purpose of population health screening. Participant phenotype was not available at the time of variant classification. Additional details can be found in publication PMID: 35346344, PMCID: PMC8962531</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB14382316</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="430594" SubmissionDate="2021-09-25" DateLastUpdated="2017-03-08" DateCreated="2015-07-05">
        <ClinVarSubmissionID localKey="GDXSV:154112" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000234296" DateUpdated="2017-03-08" DateCreated="2015-07-05" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Published functional studies demonstrate a damaging effect as mRNA and immunoblot studies showed significantly reduced product, suggesting nonsense-mediated decay, and in vitro analysis corroborated a damaging effect to channel function (Nof et al., 2010; Zarraga et al., 2011); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Reported in ClinVar as a pathogenic variant (ClinVar Variant ID# 200672; Landrum et al., 2016); This variant is associated with the following publications: (PMID: 22988594, 21215473, 21419236, 24065925, 20181576, 23304551, 28363160, 10973849, 27000522, 22956155, 30369311, 26669661, 29739726, 16922724, 32383558)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:25885</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000238.2:c.2775dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2658469" SubmissionDate="2024-01-25" DateLastUpdated="2024-02-14" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkc5Zr3pG95uxPLq06aLIsRI|MedGen:C0003811" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001350153" DateUpdated="2024-02-14" DateCreated="2020-06-22" Type="SCV" Version="3" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10973849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20181576</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21419236</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26669661</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27000522</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30369311</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32383558</ID>
          </Citation>
          <Comment>This variant causes a duplication of 1 nucleotide in exon 12 of the KCNH2 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. Functional studies have shown that this variant causes decreased expression of KCNH2 resulting in a reduction in channel current density in HEK293 cells (PMID: 20181576, 21419236). This variant has been reported in at least eight unrelated individuals affected with long QT syndrome (PMID: 10973849, 21419236, 20181576, 26669661, 30369311, 32383558). It has been shown that this variant segregates with disease in multiple individuals from two of these families (PMID: 20181576, 21419236). This variant has also been reported in an individual affected with sudden cardiac death (PMID: 27000522). This variant has been identified in 1/127658 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of KCNH2 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000238.4:c.2775dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0003811" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Color Genomics - ClinVar Submission - May2020 - SUB747</SubmissionName>
          <SubmissionName>SUB10927044</SubmissionName>
          <SubmissionName>SUB14171678</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8353011" SubmissionDate="2024-01-24" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="3873547|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004562515" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The KCNH2 c.2775dup; p.Pro926Alafs*14 variant (rs794728455) is reported in the literature in multiple individuals in the heterozygous state affected with Long QT syndrome (Choi 2021, Nof 2010, Westphal 2020, Zarraga 2011). This variant is reported in ClinVar (Variation ID: 200672) and is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. In vitro/In vivo functional analyses demonstrate reduced cellular currents (Nof 2010, Zarraga 2011). This variant causes a frameshift by inserting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Choi SH et al. Rare Coding Variants Associated with Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-Ancestry Analysis. Circ Genom Precis Med. 2021. PMID: 34319147. Nof E et al. A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death. Circ Cardiovasc Genet. 2010. PMID: 20181576. Westphal DS. Reclassification of genetic variants in children with long QT syndrome. Mol Genet Genomic Med. 2020. PMID: 32383558. Zarraga IG et al. Nonsense-mediated mRNA decay caused by a frameshift mutation in a large kindred of type 2 long QT syndrome. Heart Rhythm. 2011. PMID: 21419236.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2024</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/xwiqgyug/arup_molecular_germline_variant_investigation_process_arup-info-0022_2024.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.150644890dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023 ARUP ClinVar submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="601480" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2016-10-02">
        <ClinVarSubmissionID localKey="a886666|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000319786" DateUpdated="2024-05-01" DateCreated="2016-10-02" Type="SCV" Version="7" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10973849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20181576</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21419236</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27000522</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32383558</ID>
          </Citation>
          <Comment>The c.2775dupG pathogenic mutation, located in coding exon 12 of the KCNH2 gene, results from a duplication of G at nucleotide position 2775, causing a translational frameshift with a predicted alternate stop codon (p.P926Afs*14). This alteration was identified in several members of a large long QT syndrome type 2 (LQTS2) kindred with complete segregation in affected individuals (Zarraga IG et al. Heart Rhythm. 2011;8(8):1200-6). Functional analysis from this group demonstrated this duplication results in the absence of protein from this allele. This alteration was also reported in affected relatives in a family with a history of sudden cardiac death and prolonged QTc intervals (Cann F et al, 2017 01;91:22-29). Additionally, this alteration was reported as heterozygous in a child and mother both affected with LQTS2. The mother had a history of two other pregnancies with this alteration in addition to a paternally inherited KCNH2 alteration; these babies did not survive, and functional studies indicated that the effect of both alterations together is more severe than either alone (Nof E et al. Circ Cardiovasc Genet. 2010;3(2):199-206). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000238.3:c.2775dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="430594" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="35786" TraitType="Disease" MappingType="Name" MappingValue="LONG QT SYNDROME 1/2, DIGENIC" MappingRef="Alternate">
        <MedGen CUI="C3277700" Name="Long QT syndrome 1/2, digenic" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="601480" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="35785" TraitType="Disease" MappingType="Name" MappingValue="LONG QT SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C3150943" Name="Long QT syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9024331" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0002442" MappingRef="MONDO">
        <MedGen CUI="C0023976" Name="Long QT syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8353011" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="485295" TraitType="Disease" MappingType="XRef" MappingValue="C0023976" MappingRef="MedGen">
        <MedGen CUI="C0023976" Name="Long QT syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2658469" TraitType="Disease" MappingType="XRef" MappingValue="C0003811" MappingRef="MedGen">
        <MedGen CUI="C0003811" Name="Cardiac arrhythmia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

